# Pilot Study to Evaluate the Effects of a Generic Goserelin Acetate in Patients With Prostate Cancer

> **NCT04060043** · EARLY_PHASE1 · COMPLETED · sponsor: **CMX Research** · enrollment: 11 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Goserelin Acetate

## Key facts

- **NCT ID:** NCT04060043
- **Lead sponsor:** CMX Research
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-21
- **Primary completion:** 2017-12-06
- **Final completion:** 2018-01-02
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2021-05-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04060043

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04060043, "Pilot Study to Evaluate the Effects of a Generic Goserelin Acetate in Patients With Prostate Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04060043. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*